# Guangzhou Fiberlink Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/guangzhou-fiberlink-biotechnology-co

- Industry: Biotechnology
- Headquarters: Guangzhou, China
- Latest round: Angel (Mar 6, 2026)
- Investors on record: 1

## About

Based in Guangzhou, China and founded in 2022, Guangzhou Fiberlink Biotechnology Co., Ltd. is a high-tech enterprise specializing in the research and application of whole-structure fibronectin. In March 2026, Guangzhou Fiberlink Biotechnology Co., Ltd. raised an angel funding from Dongna Investment.

The company focuses on researching whole-structure fibronectin, which is a multifunctional extracellular matrix protein, playing a crucial role in cell adhesion, cell culture, wound healing, and the cardiovascular system. The company is committed to providing related technological solutions for the biopharmaceutical field and promoting its application in healthcare.

The company's revenue is generated by providing technological solutions for the biopharmaceutical field and promoting its application in healthcare.

The company will use the funding mainly for the research, development, production, and marketing of the company's full-structure fibronectin, further promoting its application in the biopharmaceutical field.

## Funding rounds

- Angel, Mar 6, 2026 — Dongna Investment

## Investors

- Dongna Investment (https://capitalatlas.ai/funds/dongna-investment) — Angel